Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Active not recruiting 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 21Gastrointestinal 10Thoracic 6Gynecologic 5Genitourinary 5Tumor-Agnostic 4Other hematologic neoplasm 4Other 3Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 1Motor Activity 1Lymphoma 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Fatigue 1

Interventions

Dexamethasone 70Cyclophosphamide 44Bortezomib 41Lenalidomide 25Melphalan 24Thalidomide 19pomalidomide 17daratumumab 14fludarabine 13carfilzomib 10Filgrastim 8Doxorubicin 8Busulfan 6isatuximab 5Prednisone 5Peripheral Blood Stem Cell Transplantation 5Calcium Dobesilate 5Bendamustine Hydrochloride 5selinexor 4sargramostim 4fludarabine phosphate 4Surveys and Questionnaires 4Etoposide 4Clarithromycin 4liposomal doxorubicin 3ixazomib 3dexamethasone acetate 3Radiotherapy 3Neoadjuvant Therapy 3Mycophenolic Acid 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Exercise × Plasma cell × Clear all
NCT00884364 2009-12-23

Exercise During Chemotherapy for Patients With Hematological Malignancies

Charite University, Berlin, Germany

Phase 3 Unknown
60 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Fatigue, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Motor Activity, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡